Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-18

Clinical Trial Update: A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the safety of etoricoxib in osteoarthritis and rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etoricoxib (etoricoxib)

Snippet

Sponsor: Organon and Co | Conditions: Rheumatoid Arthritis,Osteoarthritis | Phase 3 | Status: COMPLETED